Steven Campbell, MD, PhD

216.444.5600

Steven Campbell, MD, PhD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.444.5595
WorkFax:216.636.0770
Steven Campbell, MD, PhD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.444.5595
WorkFax:216.636.0770
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Steven Campbell, MD, PhD, is Professor of Surgery, Residency Program Director, and a member of the Section of Urologic Oncology in the Glickman Urological and Kidney Institute at Cleveland Clinic. 

He obtained his medical degrees at the University of Chicago and completed his urology residency at Cleveland Clinic (1989-1995), followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center (1995-1996).

Dr. Campbell’s primary interests include renal cell carcinoma, bladder cancer, prostate cancer, treatment-related osteoporosis and tumor angiogenesis.  His background also includes American Foundation for Urologic Disease (AFUD) and Kimmel Research Scholarship awards, and he is a former member of the American Board of Urology Examination Committee. Dr. Campbell is currently on the educational board for AFUD and the medical advisory board for the Kidney Cancer Association.  

Professional Highlights

  • Vice Chairman Urology, Center for Urologic Oncology, 2010
  • Residency Program Director, Cleveland Clinic, 2006-Present
  • Chief of Urology, Edward Hines Jr. VA Hospital, Chicago, 2001-2005
  • American Urologic Association, Boards Examination Committee, 1999-2003
  • American Joint Committee on Cancer, Committee for Staging Urologic Cancers, 2006-2010
  • Society of Urologic Oncology, Examination Committee

Education & Fellowships

Fellowship - Memorial Sloan-Kettering Cancer Center
Urology/Oncology
New York, NY USA
1996
Residency - Cleveland Clinic
Urology
Cleveland, OH USA
1995
Internship - Cleveland Clinic
Urology
Cleveland, OH USA
1990
Medical School - University of Chicago Pritzker School of Medicine
Chicago, IL USA
1989
Graduate - University of Chicago
Chicago, IL USA
1987
Undergraduate - University of Chicago
Biology
Chicago, IL USA
1982

Certifications

  • Urology

Specialty Interests

Adrenal cancer, bladder cancer, complex renal cysts, kidney cancer, osteoporosis related to cancer, penile cancer, prostate cancer, testis cancer, transitional cell carcinoma, urologic oncology

Awards & Honors

  • Best Doctors in Cleveland, 2006, 2007
  • America’s Top Doctors for Cancer, 2004-2006
  • America’s Top Physicians, 2004, 2005
  • Best Doctors in America, 2003-2005      
  • Kimmel Research Scholar, 1999-2001
  • American Foundation for Urologic Disease Research Scholar, 1996-1998
  • Medical Scientist Training Program Scholarship Recipient, 1982-1989
  • A.A. Stagg Academic/Athletic Scholarship, University of Chicago, 1978-1982
  • Alpha Omega Alpha, 1989
  • Phi Beta Kappa, 1981
  • George and Grace Crile Traveling Fellowship Award, Cleveland Clinic Foundation, 1994      

Additional Training

  • Robotic training seminars
  • Laparoscopic surgery training seminars
  • Laser surgery training seminars

Innovations & Patents

Dr. Campbell is active in laparoscopic surgery for the kidney and bladder and robotic surgery for the prostate, as well as new techniques for partial nephrectomy.

Memberships

  • American Urologic Association
  • Society of Urologic Oncology
  • Society of Pelvic Surgeons
  • American College of Surgeons
  • Society for Basic Urologic Research

Treatment & Services

  • Bladder Tumor Biopsy And Resection
  • Brachytherapy
  • Partial Nephrectomy
  • Prostate Biopsy
  • Radical Cystectomy
  • Radical Nephrectomy: Laparoscopic Or Open
  • Radical Orchiectomy
  • Radical Prostatectomy
  • Retroperitoneal Lymph Node Dissection
  • Robotic Prostate Surgery
  • Urology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Campbell's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

Languages Spoken

  • English
Cleveland Clinic Mobile Site